Cimeio

Cimeio Therapeutics is a company developing gene editing, cell, and immunotherapy treatments, creating a portfolio of Shielded-Cell & Immunotherapy Pairs for patients with life-threatening diseases. Our proprietary technology platform is based on the discovery of novel protein variants. This technology holds significant therapeutic potential, and we are utilizing it to develop treatments for patients with genetic disorders, hematologic malignancies, and severe autoimmune diseases.